The hyperlink to a bill draft that precedes a summary contains the most recent version (Introduced/GA/Enacted) of the bill. If the session has ended, the hyperlink contains the latest version of the bill at the time of sine die adjournment. Note that the summary pertains to the bill as introduced, which is often different from the most recent version.
SB 57 (BR 110) - C. Embry Jr., C. McDaniel
AN ACT relating to use of experimental treatments for terminal illnesses.
Create new sections of KRS Chapter 217 to define terms; permit eligible patients to use investigational drugs, biological products, or devices for a terminal illness; establish the conditions for use of such experimental treatments; prohibit sanctions of health care providers; clarify the duties of health care insurers regarding experimental treatments; prohibit certain actions by state officials.
Jan 06, 2016 - introduced in Senate
Jan 07, 2016 - to Health & Welfare (S)